Tadalafil Placebo
Sponsors
Donald T. Weed, MD, FACS, Dongkook Pharmaceutical Co., Ltd., EMS, Beni-Suef University
Conditions
Acute Urinary RetentionBenign Prostatic HyperplasiaBenign Prostatic ObstructionErectile DysfunctionHead and Neck CancerHead and Neck Squamous Cell CarcinomaPremature Ejaculation
Phase 1
Phase 3
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
CompletedNCT04947631
Start: 2021-07-27End: 2023-06-12Updated: 2023-09-21
Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation
Not yet recruitingNCT05052879
Start: 2024-07-31End: 2026-08-31Target: 232Updated: 2023-04-12
Phase 4
L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction
RecruitingNCT07642505
Start: 2026-06-08End: 2026-12-01Target: 133Updated: 2026-06-12
Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia
RecruitingNCT07654413
Start: 2026-06-08End: 2027-12-01Target: 320Updated: 2026-06-17